KLK3 and posterior cortical atrophy: European scientific societies have promoted using biomarker tests, mainly from blood, urine, imaging, or tissue-based [5]in patients with known PSA values to improve specificity and avoid over diagnosing non-significant PCa (ISUP 1) [6].